Abstract
Purpose To investigate the role of the shared epitope alleles in determining susceptibility to and the phenotype of corneal melting in patients with rheumatoid arthritis (RA).
Methods The HLA class 1 and 2 genotype was determined for 17 patients with rheumatoid-associated corneal melting by the phototyping method. HLA-DR4 subtyping was performed by PCR sequence-based typing. The frequency of all the shared epitope alleles and, in particular, of the higher-risk *0401 and *0404 alleles, was compared with healthy controls and unrelated RA patients, with and without extra-articular manifestations. A comparison was also made between the shared epitope genotype of the corneal melt patients and local, ocular disease characteristics.
Results Thirteen (76%) patients with corneal melt possessed at least one shared epitope allele and 5 (29%) possessed two alleles. The dominant alleles were variants of the DR4 family, notably the *0401, *0404 and *0408 alleles. Both the allele frequency and a double dose of shared epitope alleles were more common in the three RA patient groups than in the healthy, control group (p < 0.005). Although the frequency of the higher-risk alleles was similar in the three RA patient group, a trend existed for a double dose of higher-risk alleles to be more common in the patients with either corneal melt or other extra-articular manifestations (p > 0.2). No association was found between the number or type of shared epitope alleles and any of the ocular disease characteristics studied.
Conclusions The results of this study suggest that the shared epitope alleles do not influence the ocular disease phenotype of corneal melt in RA patients. Shared epitope determination of RA patients may help to identify those susceptible to either corneal melt or other extra-articular disease. RA patients with a double dose of higher-risk alleles may have an increased risk of corneal melt.
Similar content being viewed by others
Article PDF
References
Gregersen PK, Silver J, Winchester RJ . The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205–13.
Nepom GT . Class 2 antigens and disease susceptibility. Annu Rev Med 1995;46:17–25.
Weyand CM, McCarthy TG, Goronzy JJ . Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120–6.
Weyand CM, Goronzy JJ . Inherited and non-inherited risk factors in rheumatoid arthritis. Curr Opin Rheumatol 1995;7:206–13.
McMahon MJ, Hillarby M, Clarkson RWE, Hollis S, Grennan DM . Major histocompatibility complex variants and articular disease severity in rheumatoid arthritis. Br J Rheum 1993;32:899–902.
MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A . HLA-DRBl*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset and disease severity. J Rheumatol 1995;22:1032–6.
Hall FC, Weeks DE, Camilleri JP, Williams LA, Amos N, Darke C, et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Q J Med 1996;89:821–9.
Deighton CM, Cavanagh G, Rigby AS, Lloyd HL, Walker DJ . Both inherited haplotypes are important in the predisposition to rheumatoid arthritis. Br J Rheum 1993;32:893–8.
Bernauer W, Ficker LA, Watson PG, Dart JKG . The management of corneal perforations associated with rheumatoid arthritis: an analysis of 32 eyes. Ophthalmology 1995;102:1325–37.
Foster CS, Forstot SL, Wilson LA . Mortality rate in rheumatoid arthritis patients developing necrotising scleritis or peripheral ulcerative keratitis. Ophthalmology 1984;91:1253–63.
Miller SA, Dykes DD, Polesky HT . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, et al. Phototyping: comprehensive DNA typing for HLA-A,B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence specific primers. Tissue Antigens 1995;46:355–67.
Griffiths B, Situnayake RD, Clark B, Tennant A, Salmon M, Emery P . Racial origin and its effect on disease expression and HLA-DRB1 types in patients with RA: a matched cross-sectional study. Rheumatology 2000;39:857–64.
Taylor CJ, Dyer PA . Histocompatibility antigens. Eye 1995;9:173–9.
Weyand CM, Goronzy JJ . Pathogenesis of rheumatoid arthritis. Med Clin North Am 1997;81:29–55
Messmer EM, Foster CS . Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999;43:379–96.
McKibbin M, Isaacs JD, Morrell AJ . The incidence of corneal melting in association with systemic diease in the Yorkshire Region, 1995-1997. Br J Ophthalmol 1999;83:941–3.
Scott DG, Bacon PA, Tribe CR . Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine 1981;60:288–97.
Messmer EM, Foster CS . Destructive corneal and scieral disease associated with rheumatoid arthritis. Cornea 1995;14:408–17.
Emery P, Salmon M . Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:9447.
Riley GP Harrall RL, Watson PG, Cawston TE, Hazelman BL Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye 1995;9:703–8.
Smith VA, Hoh HB, Easty DL . Role of matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol 1999;83:1376–83.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funded by a grant from the Northern and Yorkshire Regional Health Authority
Presented at the Oxford Ophthalmological Congress, July 2000
Rights and permissions
About this article
Cite this article
McKibbin, M., Clark, B., Isaacs, J. et al. Does the shared epitope genotype influence either the susceptibility to or the phenotype of corneal melting?. Eye 15, 492–496 (2001). https://doi.org/10.1038/eye.2001.161
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.161